Your browser doesn't support javascript.
loading
Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis.
Ledoult, Emmanuel; Launay, David; Béhal, Hélène; Mouthon, Luc; Pugnet, Grégory; Lega, Jean-Christophe; Agard, Christian; Allanore, Yannick; Jego, Patrick; Fauchais, Anne-Laure; Harlé, Jean-Robert; Berthier, Sabine; Aouba, Achille; Mekinian, Arsène; Diot, Elisabeth; Truchetet, Marie-Elise; Boulon, Carine; Duhamel, Alain; Hachulla, Eric; Sobanski, Vincent.
Afiliação
  • Ledoult E; Univ. Lille, Institute for Translational Research in Inflammation (INFINITE), F-59000, Lille, France.
  • Launay D; CHU Lille, Service de Médecine Interne, Centre de Référence des Maladies Auto-immunes et Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000, Lille, France.
  • Béhal H; INSERM, U1286, F-59000, Lille, France.
  • Mouthon L; Univ. Lille, Institute for Translational Research in Inflammation (INFINITE), F-59000, Lille, France.
  • Pugnet G; CHU Lille, Service de Médecine Interne, Centre de Référence des Maladies Auto-immunes et Systémiques Rares du Nord et Nord-Ouest de France (CeRAINO), F-59000, Lille, France.
  • Lega JC; INSERM, U1286, F-59000, Lille, France.
  • Agard C; Univ. Lille, CHU Lille, EA 2694-Santé publique, épidémiologie et qualité des soins, Unité de Biostatistiques, F-59000, Lille, France.
  • Allanore Y; Hôpital Cochin-APHP, Service de Médecine Interne, Paris, France.
  • Jego P; CHU Toulouse, Service de Médecine Interne, Toulouse, France.
  • Fauchais AL; CHU Lyon Sud, Service de Médecine Interne, Pierre-Bénite, France.
  • Harlé JR; CHU Nantes, Service de Médecine Interne, Nantes, France.
  • Berthier S; Hôpital Cochin-APHP, Service de Rhumatologie, Paris, France.
  • Aouba A; CHU Rennes, Service de Médecine Interne, Rennes, France.
  • Mekinian A; CHU Limoges, Service de Médecine Interne, Limoges, France.
  • Diot E; Hôpital de la Timone, Service de Médecine Interne, Marseille, France.
  • Truchetet ME; CHU Dijon, Service de Médecine Interne et Immunologie Clinique, Dijon, France.
  • Boulon C; CHU Caen, Service de Médecine Interne, Caen, France.
  • Duhamel A; Hôpital Saint-Antoine-APHP, Service de Médecine Interne, Paris, France.
  • Hachulla E; CHU Tours, Service de Médecine Interne, Tours, France.
  • Sobanski V; CHU Bordeaux, Service de Rhumatologie, Bordeaux, France.
Arthritis Res Ther ; 22(1): 30, 2020 02 18.
Article em En | MEDLINE | ID: mdl-32070422
BACKGROUND: Systemic sclerosis (SSc) is a severe and highly heterogeneous disease. The modified Rodnan skin score (mRSS) is a widely used tool for the assessment of the extent and degree of skin thickness. This study aimed to identify the classes of patients with early similar skin thickening trajectories without any a priori assumptions and study their associations with organ involvement and survival. METHODS: From the French SSc national cohort, patients with a disease duration of less than 2 years at inclusion and with at least 2 mRSS available within the first 4 years of follow-up were enrolled. Classes of patients with similar mRSS trajectories were identified based on a latent class mixed model. The clinical characteristics and survival rate were compared between the obtained classes. RESULTS: A total of 198 patients fulfilled the inclusion criteria, with a total of 641 mRSS available. The median disease duration and follow-up were 0.8 (interquartile range 0.4; 1.2) and 6.3 (3.8; 8.9) years, respectively. Individual trajectories of mRSS were highly heterogeneous between patients. Models with 1-6 latent classes of trajectories were sequentially assessed, and the 5-class model represented the best fit to data. Each class was characterized by a unique global trajectory of mRSS. The median disease duration did not differ significantly between classes. Baseline organ involvement was more frequent in classes with significant change over time (classes 2-5) than in class 1 (low baseline mRSS without significant change over time). Using Cox regression, we observed a progressively increasing risk of death from classes 1 to 5. CONCLUSIONS: Early identification of clinical phenotype based on skin thickening trajectories could predict morbi-mortality in SSc. This study suggested that mRSS trajectories characterization might be pivotal for clinical practice and future trial designs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Pele Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Arthritis Res Ther Assunto da revista: REUMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Escleroderma Sistêmico / Pele Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Arthritis Res Ther Assunto da revista: REUMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
...